Mangoceuticals, Inc. (MGRX) Operating margin 2022–2025
Mangoceuticals, Inc. (MGRX) operating margin by fiscal year — reported operating income divided by reported revenue.
-3954.3%FY2025 · since FY2022: -22279.7% → -3954.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -3954.3% | -2659.9 pp |
| FY2024 | -1294.4% | -34.1 pp |
| FY2023 | -1260.3% | +21019.4 pp |
| FY2022 | -22279.7% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More MGRX financial trends
MGRX RevenueMGRX Net incomeMGRX Net marginMGRX Gross profitMGRX Gross marginMGRX Operating incomeMGRX Operating cash flowMGRX Free cash flowMGRX Capital expendituresMGRX Return on equityMGRX Stock buybacksMGRX Dividends paidMGRX Total assetsMGRX Total liabilitiesMGRX Shareholders’ equityMGRX overview →